Carcinoma, Squamous Cell: all 1,779 studies

Page 12 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.

• A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT03857763Phase 2
• Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）Status unknownNCT03855384Phase 3
• A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
• Hyperbaric Radiation Sensitization of Head and Neck CancersStatus unknownNCT03843671Phase 2
• Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response PredictionStatus unknownNCT03843515Phase 1
• FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsCompletedNCT03841110Phase 1
• Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.Status unknownNCT03837613
• Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenWithdrawnNCT03834571Phase 2
• Nivolumab in Patients With Advanced Cutaneous Squamous Cell CarcinomaStatus unknownNCT03834233Phase 2
• Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)Status unknownNCT03833466Phase 2
• A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT03818542Phase 1
• A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCCStatus unknownNCT03817658Phase 2
• Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03817567Phase 1/2
• Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCCActive, not recruitingNCT03813836Phase 2
• The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03800953Phase 2
• Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell CarcinomaStatus unknownNCT03799744Phase 1
• PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2
• Smoking Tobacco Cessation Integrated Program of Patients Treated for the Head and the Neck CancerCompletedNCT03788785Not applicable
• Postmenopausal Women With Vaginal MicrobiotaStatus unknownNCT03786601
• Rigosertib for RDEB-SCCCompletedNCT03786237Phase 1/2
• Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT03785496Phase 2
• Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral CavityActive, not recruitingNCT03784066Phase 1/2
• Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcerCompletedNCT03777813Phase 2
• Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerStatus unknownNCT03775525Phase 1
• Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaStatus unknownNCT03774901Phase 2
• MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell CarcinomaWithdrawnNCT03773744Phase 1
• A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)Status unknownNCT03770988Phase 2
• Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot TrialStatus unknownNCT03769285Phase 2
• Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03766178Phase 2
• Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior TherapyCompletedNCT03762564Phase 2
• Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell CarcinomaCompletedNCT03759756
• IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid TumorsCompletedNCT03758781Phase 1
• Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )CompletedNCT03748134Phase 3
• SCT200 Injection in Patients With Head and Neck Squamous Cell CarcinomaStatus unknownNCT03744208Phase 2
• Study Assessing the Safety and Performance of Smart Matrix®Status unknownNCT03742726Not applicable
• Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Active, not recruitingNCT03737734Not applicable
• A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced CancerTerminatedNCT03735290Phase 1
• SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell CancerStatus unknownNCT03732508Phase 2
• TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the NeckCompletedNCT03729518Not applicable
• Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT03727594
• Apatinib for Advanced Lung Squmamous CarcinomaStatus unknownNCT03725423Phase 4
• FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/PaclitaxelCompletedNCT03723967Phase 2
• CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity CancerCompletedNCT03721757Phase 2
• Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer PatientsTerminatedNCT03720158Not applicable
• Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell CarcinomaCompletedNCT03719924Phase 2
• Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) TrialStatus unknownNCT03713749Not applicable
• Safety and Efficacy of SCT200 in Head and Neck Squamous Cell CarcinomaStatus unknownNCT03713372Phase 2
• Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT03708224Phase 2
• Early Detection of Head and Neck Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell CarcinomaStatus unknownNCT03700398Not applicable
• Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.CompletedNCT03697226Phase 1
• Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)CompletedNCT03695510Phase 2
• Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid TumorsTerminatedNCT03684785Phase 1/2
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionTerminatedNCT03677960Phase 1
• A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPCActive, not recruitingNCT03669718Phase 2
• Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CancerCompletedNCT03667482Phase 1
• Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell CarcinomaCompletedNCT03660449Phase 2
• Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT03652233Phase 1
• Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell CarcinomaStatus unknownNCT03652142
• Biofeedback Rehabilitation to Improve Speaking and Eating in PublicCompletedNCT03650699Not applicable
• Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCCCompletedNCT03624231Phase 2
• Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCCStatus unknownNCT03623737Phase 2/3
• A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and NeckCompletedNCT03620123Phase 2
• Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell LineStatus unknownNCT03619304Not applicable
• Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell CarcinomaCompletedNCT03618654Early Phase 1
• Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell CanerTerminatedNCT03618134Phase 1/2
• Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and NeckStatus unknownNCT03614936
• Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation TherapyWithdrawnNCT03611205Not applicable
• SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerStatus unknownNCT03603756Phase 2
• Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT03600831Phase 2/3
• Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT03590054Phase 1
• Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaStatus unknownNCT03585673Phase 2
• Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of EsophagusStatus unknownNCT03585530Phase 2
• Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerStatus unknownNCT03579004Phase 2
• Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity StudyCompletedNCT03575598Early Phase 1
• Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal CancerWithdrawnNCT03575234Phase 1
• Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell CarcinomaCompletedNCT03554967
• ctDNA as a Biomarker for Treatment Response in HNSCCCompletedNCT03540563Not applicable
• Salivary Ap4A, SCCA, TROP2 in Oral Cancer PatientsStatus unknownNCT03529604
• Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell CarcinomaCompletedNCT03524326Phase 1
• A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
• Early Response Evaluation of Proton Therapy by PET-imaging in Squamous Cell Carcinoma Located in the Head and NeckTerminatedNCT03513042
• Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue OxygenationCompletedNCT03510390Not applicable
• Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
• Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT03498378Phase 1
• EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck CancerCompletedNCT03494322Phase 2
• Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell CarcinomaNo longer availableNCT03492489
• Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell CarcinomaStatus unknownNCT03486509Phase 2
• Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical CancerStatus unknownNCT03469531Phase 2
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System NeoplasmsStatus unknownNCT03468244Not applicable
• Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot StudyCompletedNCT03467529
• Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar CancersCompletedNCT03452332Phase 1
• Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCCStatus unknownNCT03450967Phase 2
• Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell CarcinomaStatus unknownNCT03440151Not applicable
• A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT03433027Phase 2
• A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT03424291Phase 2
• PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved SwallowingWithdrawnNCT03423264Phase 2
• Functional Outcome After Treatment for Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT03418909
• A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell CancerCompletedNCT03416244Phase 2
• Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell CarcinomaCompletedNCT03404921Not applicable
• Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or HypopharynxWithdrawnNCT03388931Phase 4

← Carcinoma, Squamous Cell overview